<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To identify candidate antigens in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA), we screened proteins derived from a <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell line with serum of an AA patient and identified <z:chebi fb="11" ids="49575">diazepam</z:chebi>-binding inhibitor-related protein 1 (DRS-1) </plain></SENT>
<SENT sid="1" pm="."><plain>Enzyme-linked immunosorbent assay (ELISA) revealed high titers of anti-DRS-1 antibodies (DRS-1 Abs) in 27 (38.0%) of 71 AA patients displaying increased <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>)-type cells (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>(+)), 2 (6.3%) of 32 PNH(-) AA patients, 5 (38.5%) of 13 PNH(+) <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) patients, and none of 42 PNH(-) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>DRS-1 gene was abundantly expressed in myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines and in CD34(+) cells derived from healthy individuals </plain></SENT>
<SENT sid="3" pm="."><plain>Stimulation of T cells from an AA patient displaying high DRS-1 Abs with a putative CD4(+) T-cell <z:chebi fb="0" ids="53000">epitope</z:chebi> (amino acid residues [aa's] 191-204) presented by HLA-DR15, which overlapped with a hot spot (aa's 173-198) of DRS-1 Ab <z:chebi fb="0" ids="53000">epitopes</z:chebi>, gave rise to T cells cytotoxic for L cells (murine fibroblasts) that were transfected with DRB1*1501 and DRS-1 </plain></SENT>
<SENT sid="4" pm="."><plain>Enzyme-linked immunospot assay demonstrated increased frequency of T-cell precursors specific to the DRS-1 peptide in other HLA-DR15(+) AA patients displaying high DRS-1 Ab titers </plain></SENT>
<SENT sid="5" pm="."><plain>These findings indicate that DRS-1 may serve as an autoantigen eliciting immune attack against hematopoietic stem cells in a subset of AA patients characterized by increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-type cells </plain></SENT>
</text></document>